Interventions to reduce non-prescription antimicrobial sales in community pharmacies
- PMID: 39878150
- PMCID: PMC12043199
- DOI: 10.1002/14651858.CD013722.pub2
Interventions to reduce non-prescription antimicrobial sales in community pharmacies
Abstract
Background: Antimicrobial resistance (AMR) is a major global health concern. One of the most important causes of AMR is the excessive and inappropriate use of antimicrobial drugs in healthcare and community settings. Most countries have policies that require antimicrobial drugs to be obtained from a pharmacy by prescription. The term 'non-prescription antimicrobial sale' refers to the dispensing and selling of antimicrobial drugs without a prescription in countries where the pharmaceutical policy does not permit the sale of antimicrobial drugs without a prescription. Pharmacies, drugstores, and other medicine outlets are major sources of non-prescription antimicrobial sales in the community setting.
Objectives: To assess the effects of interventions for reducing non-prescription antimicrobial sales by pharmacists and non-pharmacists in community pharmacies, drugstores, and other medicine outlets. To assess whether the effects of interventions differ according to types of interventions (single or multicomponent), community pharmacy personnel (pharmacists or non-pharmacists), and countries (low to lower-middle-income and upper-middle to high income).
Search methods: We searched five databases, including CENTRAL, MEDLINE, and Embase, and two trial registers to 26 September 2022. We also conducted reference checking and citation searches.
Selection criteria: We included randomized trials, cluster-randomized trials, and quasi-randomized trials evaluating interventions targeted at pharmacists and non-pharmacists in community pharmacies, drugstores, and other medicine outlets. Our primary outcomes were non-prescription antimicrobial sales, symptomatic or asymptomatic infections caused by antimicrobial-resistant pathogens among pharmacy clients or community residents, and adverse events associated with non-prescription antimicrobial drug use in pharmacy clients. Our secondary outcomes were history taking and provision of advice to pharmacy clients, and knowledge of pharmacists and non-pharmacists.
Data collection and analysis: We followed standard Cochrane methods.
Main results: We included four trials conducted in pharmacies and drugstores. Three studies were published between 2000 and 2010, and the fourth in 2016. In total, 942 community pharmacies and drugstores participated, including both pharmacists and non-pharmacists. One study conducted in Scotland was a four-arm trial that included educational outreach visits, continuing professional education, and a combination of both as interventions, in comparison to a control group supplied with guideline materials only. Two studies conducted in Portugal and Uganda compared the combination of training and distribution of written materials with a control of no intervention. One study conducted in Thailand and Vietnam compared a sequence of three interventions (regulatory enforcement, education, and peer-monitoring) with a control of no intervention. Only non-prescription antimicrobial sales, history taking and provision of advice to pharmacy clients, and knowledge of pharmacists and non-pharmacists were assessed in the included studies; no study assessed other outcomes. We judged the overall risk of bias for non-prescription antimicrobial sales to be high risk and for the other two outcomes to be some concerns. One study conducted in Scotland assessed single-component interventions (in two intervention arms) versus a control of written guidelines, and reported one primary outcome and one secondary outcome. Non-prescription antimicrobial sales: the study reported the sale or non-sale of antifungal drugs according to simulated patient scenarios. It did not report any differences between the intervention and control groups for the scenarios in which antifungal drugs should not have been sold without a prescription. The certainty of evidence for this outcome was very low. Knowledge of pharmacists and non-pharmacists: the study reported knowledge scores at baseline and follow-up, but did not compare the scores between two single-component intervention arms and the control arm at both time points. Four studies assessed multicomponent interventions versus a control of written guidelines or no intervention, and reported one primary outcome and two secondary outcomes. Non-prescription antimicrobial sales:two studies conducted in Uganda, Thailand, and Vietnam involving 337 randomized community pharmacies and drugstores reported the proportion of non-prescription antimicrobial sales to the total number of requests using a simulated client method. Based on vote counting, both studies favored the intervention, that is multicomponent interventions reduced the sales of non-prescription antimicrobial drugs by pharmacists and non-pharmacists. The information in the other two studies was inadequate to address this primary outcome. One study in Portugal reported that total antibiotic consumption at the municipal level (comprising both prescribed and non-prescribed antibiotic sales) was reduced after a multicomponent intervention. The study conducted in Scotland assessed a multicomponent intervention (in one intervention arm) and reported the sale or non-sale of antifungal drugs according to simulated patient scenarios. It did not report any differences between the intervention and control groups for the scenarios in which antifungal drugs should not have been sold without a prescription. The certainty of evidence for this outcome was very low. History taking and provision of advice to pharmacy clients:two studies conducted in Uganda, Thailand, and Vietnam reported this outcome. In Thailand and Vietnam, there was an improvement in the practices of pharmacists and non-pharmacists in the intervention groups, while Uganda reported a paradoxical decline. Knowledge of pharmacists and non-pharmacists:the study conducted in Scotland reported knowledge scores at baseline and follow-up, but did not compare the scores between the multicomponent intervention arm and control arm at both time points.
Authors' conclusions: No firm conclusions can be drawn about the effects of single-component interventions due to limited evidence. Multicomponent interventions may not reduce the sales of non-prescription antimicrobial drugs in community pharmacies, drugstores, and other medicine outlets; however, the evidence is of very low certainty. Further studies on this topic are needed, particularly to assess the effects of important single interventions such as improving pharmaceutical policies.
Copyright © 2025 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Conflict of interest statement
MMT: none known
TB: none known
SM: none known
EO: none known
Update of
- doi: 10.1002/14651858.CD013722
Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Public stewardship of private for-profit healthcare providers in low- and middle-income countries.Cochrane Database Syst Rev. 2016 Aug 11;2016(8):CD009855. doi: 10.1002/14651858.CD009855.pub2. Cochrane Database Syst Rev. 2016. PMID: 27510030 Free PMC article.
-
Topical antibiotics for chronic suppurative otitis media.Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013051. doi: 10.1002/14651858.CD013051.pub3. Cochrane Database Syst Rev. 2025. PMID: 40484407
-
Professional, structural and organisational interventions in primary care for reducing medication errors.Cochrane Database Syst Rev. 2017 Oct 4;10(10):CD003942. doi: 10.1002/14651858.CD003942.pub3. Cochrane Database Syst Rev. 2017. PMID: 28977687 Free PMC article.
References
References to studies included in this review
Chalker 2005 {published data only}
-
- Chalker J, Chuc NT, Falkenberg T, Tomson G. Private pharmacies in Hanoi, Vietnam: a randomized trial of a 2-year multi-component intervention on knowledge and stated practice regarding ARI, STD and antibiotic/steroid requests. Tropical Medicine and International Health 2002;7(9):803-10. [PMID: 10.1046/j.1365-3156.2002.00934.x] [PMID: ] - DOI - PubMed
-
- Chalker J, Ratanawijitrasin S, Chuc NT, Petzold M, Tomson G. Effectiveness of a multi-component intervention on dispensing practices at private pharmacies in Vietnam and Thailand—a randomized controlled trial. Social Science and Medicine 2005;60(1):131-41. [DOI: 10.1016/j.socscimed.2004.04.019] [PMID: ] - DOI - PubMed
Roque 2016 {published data only}
Tumwikirize 2004 {published data only}
-
- Tumwikirize WA, Ekwaru PJ, Mohammed K, Ogwal-Okeng JW, Aupont O. Impact of a face-to-face educational intervention on improving the management of acute respiratory infections in private pharmacies and drug shops in Uganda. East African Medical Journal 2004;Suppl:S25-32. [PMID: ] - PubMed
Watson 2002 {published data only}
References to studies excluded from this review
Arparsrithongsagul 2015 {published data only}
Ashiru‐Oredope 2020 {published data only}
-
- Ashiru-Oredope D, Doble A, Thornley T, Saei A, Gold N, Sallis A, et al. Improving management of respiratory tract infections in community pharmacies and promoting antimicrobial stewardship: a cluster randomised control trial with a self-report behavioural questionnaire and process evaluation. Pharmacy 2020;8(1):44. [DOI: 10.3390/pharmacy8010044] [PMID: ] - DOI - PMC - PubMed
Chowdhury 2018 {published data only}
-
- Chowdhury F, Sturm-Ramirez K, Mamun AA, Iuliano AD, Chisti MJ, Ahmed M, et al. Effectiveness of an educational intervention to improve antibiotic dispensing practices for acute respiratory illness among drug sellers in pharmacies, a pilot study in Bangladesh. BMC Health Services Research 2018;18:1-11. [DOI: 10.1186/s12913-018-3486-y] - DOI - PMC - PubMed
Collins 2017 {published data only}
Contopoulos‐Ioannidis 2001 {published data only}
CTRI/2021/01/030448 {published data only}
-
- CTRI/2021/01/030448. Improving awareness regarding antimicrobial resistance among doctors and pharmacists. Clinical Trials Registry - India.
Friis 1991 {published data only}
-
- Friis H, Bro F, Mabeck CE, Vejlsgaard R. Changes in prescription of antibiotics in general practice in relation to different strategies for drug information. Danish Medical Bulletin 1991;38(4):380-82. [PMID: ] - PubMed
Garcia 2003 {published data only}
Hoa 2017 {published data only}
-
- Hoa NQ, Lan PT, Phuc HD, Chuc NTK, Lundborg CS. Antibiotic prescribing and dispensing for acute respiratory infections in children: effectiveness of a multi-faceted intervention for health-care providers in Vietnam. Global Health Action 2017;10:1-10. [DOI: doi: 10.1080/16549716.2017.1327638.] - PMC - PubMed
Hussain 2012 {published data only}
-
- Hussain A, Ibrahim MIM, Malik M. Impact of training of dispensers on case management of acute respiratory tract infections at community pharmacies in Pakistan. Pharmacology & Pharmacy 2012;3:485-91. [DOI: 10.4236/pp.2012.34067] - DOI
Lan 2014 {published data only}
NCT04331340 {published data only}
-
- NCT04331340. Management of LUTS by community pharmacists. clinicaltrials.gov/show/NCT04331340.
Schneider 2013 {published data only}
-
- Schneider CR, Emery L, Brostek R, Clifford RM. Evaluation of the supply of antifungal medication for the treatment of vaginal thrush in the community pharmacy setting: a randomized controlled trial. Pharmacy Practice 2013;11(3):132-7. [DOI: 10.4321/s1886-36552013000300002] [PMID: ] - DOI - PMC - PubMed
Stenson 2001 {published data only}
-
- Stenson B, Syhakhang L, Lundborg CS, Eriksson B, Tomson G. Private pharmacy practice and regulation. A randomized trial in Lao P.D.R.. Int J Technol Assess Health Care 2001;14(4):579-89. [PMID: ] - PubMed
Watson 2007 {published data only}
Weinberger 2002 {published data only}
References to ongoing studies
ISRCTN89439892 {published data only}
-
- Adolfo Figueiras Guzmán. Evaluation of the effectiveness of an educational intervention in community pharmacists to improve pharmaceutical care in upper respiratory infections, including flu, colds, sore throat and sinusitis. WHO ICTRP. [ISRCTNREGISTRY: http://www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN89439892 2018;():]
Additional references
Alhomoud 2017
-
- Alhomoud F, Aljamea Z, Almahasnah R, Alkhalifah K, Basalelah L, Alhomoud FK. Self-medication and self-prescription with antibiotics in the Middle East—do they really happen? A systematic review of the prevalence, possible reasons, and outcomes. International Journal of Infectious Diseases 2017;57:3-12. [DOI: ] - PubMed
Antimicrobial Resistance Collaborators 2022
Arnold 2005
Auta 2019
Ayukekbong 2017
Barker 2017
Bavestrello 2002
-
- Bavestrello L, Cabello A, Casanova D. Impact of regulatory measures in the trends of community consumption of antibiotics in Chile [Impacto de medidas regulatorias en la tendencia de consumo comunitario de antibióticos en Chile]. Revista Médica de Chile 2002;11:1265-72. [PMID: ] - PubMed
Booth 2013
Borenstein 2009
-
- Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. When does it make sense to perform a meta-analysis? In: Introduction to Meta-Analysis. Chichester, UK: John Wiley & Sons, Ltd, 2009.
Both 2015
-
- Both L, Botgros R, Cavaleri M. Analysis of licensed over-the-counter (OTC) antibiotics in the European Union and Norway, 2012. Euro Surveill 2015;20(34):pii=30002. [DOI: ] - PubMed
Campbell 2020
Cars 2005
-
- Cars O, Nordberg P. Antibiotic resistance—the faceless threat. International Journal of Risk & Safety in Medicine 2005;17:103-10.
Chang 2017
Chikowe 2018
Cisneros 2014
-
- Cisneros JM, Neth O, Gil-Navarro MV, Lepe JA, Jimenez-Parrilla F, Cordero E, et al. Global impact of an educational antimicrobial stewardship programme on prescribing practice in a tertiary hospital centre. Clinical Microbiology and Infection 2014;20:82-8. [DOI: 10.1111/1469-0691.12191] - DOI - PubMed
Covidence [Computer program]
-
- Covidence. Version accessed 30 July 2020. Melbourne, Australia: Veritas Health Innovation, 2020. Available at covidence.org.
Cuevas 2021
-
- Cuevas C, Batura N, Wulandari LPL, Khan M, Wiseman V. Improving antibiotic use through behaviour change: a systematic review of interventions evaluated in low- and middle-income countries. Health Policy Plan 2021;36(5):594-605. [DOI: doi: 10.1093/heapol/czab021] [PMID: PMID: 33822953] - PMC - PubMed
Dameh 2010
Davey 2017
Doron 2011
Emmerton 2005
-
- Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. Journal of Pharmacy and Pharmaceutical Science 2005;8(2):217-25. - PubMed
EPOC 2015
-
- Cochrane Effective Practice and Organisation of Care (EPOC). Effective Practice and Organisation of Care (EPOC). EPOC Taxonomy; 2015. epoc.cochrane.org/epoc-taxonomy (accessed 18 September 2019).
EPOC 2017a
-
- Cochrane Effective Practice and Organisation of Care (EPOC). Data collection form. EPOC resources for review authors, 2017. epoc.cochrane.org/epoc-specific-resources-review-authors (accessed 18 September 2019).
EPOC 2017b
-
- Cochrane Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews. EPOC resources for review authors, 2017. epoc.cochrane.org/epoc-specific-resources-review-authors (accessed 18 September 2019).
EPOC 2017c
-
- Cochrane Effective Practice and Organisation of Care (EPOC). EPOC worksheets for preparing a 'Summary of findings' table using GRADE. EPOC resources for review authors, 2017. epoc.cochrane.org/epoc-specific-resources-review-authors (accessed 18 September 2019).
Ettner 2006
-
- Ettner SL, Schoenbaum M. The role of economic incentives in improving the quality of mental healthcare. In: Andrew M Jones, editors(s). The Elgar Companion to Health Economics. 1st edition. Cornwall: Edward Elgar Publishing, 2006:286-295.
Flodgren 2011
-
- Flodgren G, Eccles MP, Shepperd S, Scott A, Parmelli E, Beyer FR. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No: CD009255. [DOI: 10.1002/14651858.CD009255] - DOI - PMC - PubMed
Founou 2017
Goossens 2005
GRADEpro GDT [Computer program]
-
- GRADEpro GDT. Version accessed 1 February 2022. Hamilton (ON): McMaster University (developed by Evidence Prime), 2014. Available at https://www.gradepro.org.
Grol 1994
Gunten 2007
-
- Gunten V, Reymond JP, Beney J. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharm World Sci 2007;29(3):146-63. [DOI: doi: 10.1007/s11096-006-9042-6] [PMID: PMID: 17273907] - PubMed
Guyatt 2008
-
- Guyatt GH, Oxman AD, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al, GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6. [DOI: 10.1136/bmj.39489.470347.AD] - DOI - PMC - PubMed
Higgins 2022
-
- Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.
Islam 2018
Iwamoto 2019
-
- Iwamoto K, Pedersen HB, Tello JE, Wong DLF, Robertson J. Cross-programmatic consultation on the role of primary care in the responsible use of medicines and the reduction of antimicrobial resistance. Expert Review of Anti-infective Therapy 2019;17(2):75-8. [DOI: 10.1080/14787210.2018.] - DOI - PubMed
Jacobs 2019
-
- Jacobs TG, Robertson J, Ham HA, Iwamoto K, Pedersen HB, Mantel-Teeuwisse AK. Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review. BMC Health Services Research 2019;19:1-15. [DOI: doi: 10.1186/s12913-019-4359-8.] [PMID: PMID: 31366363] - PMC - PubMed
Jamshed 2018
Kumpf 2014
-
- Kumpf O, Bloos F, Bause H, Brinkmann A, Deja M, Marx G, et al. Voluntary peer review as innovative tool for quality improvement in the intensive care unit—a retrospective descriptive cohort study in German intensive care units. German Medical Science 2014;12:1-23. [DOI: 10.3205/000202. eCollection 2014.] - PMC - PubMed
Laxminarayan 2013
Lefebvre 2022
-
- Lefebvre C, Glanville J, Briscoe S, Featherstone R, Littlewood A, Marshall C, et al. Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.
Li 2023
-
- Li J, Zhou P, Wang J, Li H, Xu H, Meng Y, et al. Worldwide dispensing of non-prescription antibiotics in community pharmacies and associated factors: a mixed-methods systematic review. The Lancet. Infectious Diseases 2023;23(9):e361-e370. [DOI: ] - PubMed
Liberati 2009
-
- Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6(7):e1000100. [DOI: 10.1016/j.jclinepi.2009.06.006.] - DOI - PMC - PubMed
Lim 2020
Mangham‐Jefferies 2015
-
- Mangham-Jefferies L, Hanson K, Mbacham W, Onwujekwe O, Wiseman V. Mind the gap: knowledge and practice of providers treating uncomplicated malaria at public and mission health facilities, pharmacies and drug stores in Cameroon and Nigeria. Health Policy and Planning 2015;30(9):1129-41. [DOI: ] - PMC - PubMed
McIntosh 2016
-
- McIntosh T, Stewart D, Forbes-McKay K, McCaig D, Cunningham S. Influences on prescribing decision-making among non-medical prescribers in the United Kingdom: systematic review. Fam Pract 2016;33(6):572-9. [DOI: doi: 10.1093/fampra/cmw085] [PMID: ] - PubMed
McKinn 2021
Miller 2016
Minamida 2018
Morgan 2011
Moullin 2013
-
- Moullin JC, Sabater-Hernandez D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Research in Social and Administrative Pharmacy 2013;9(6):989-95. [DOI: ] - PubMed
Mukonzo 2013
Nair 2021
Nakajima 2010
Naylor 2018
Nepal 2018
Netthong 2022
NHS Grampian 2020
-
- NHS Grampian. Patient group direction for the supply of Trimithoprim tablets by community pharmacists under the 'Pharmacy First' service. www.nhsgrampian.org/globalassets/foidocument/foi-public-documents1---all... (accessed 28 March 2022).
Norcini 2003
-
- Norcini JJ. Peer assessment of competence. The Metric of Medical Education 2003;37:539-43. [DOI: DOI: 10.1046/j.1365-2923.2003.01536.x] - PubMed
Nyazema 2007
O'Neill 2016
-
- O'Neill J. Review on antimicrobial resistance: tackling drug-resistant infections globally: final report and recommendations. www.cabidigitallibrary.org/doi/full/10.5555/20163354200.
Oleszkiewicz 2021
Raheel 2017
-
- Raheel H, Alsakran S, Alghamdi A, Ajarem M, Alsulami S, Mahmood A. Antibiotics and over the counter medication use and its correlates among Arab pregnant women visiting a tertiary care hospital in Riyadh, Saudi Arabia. Pakistan Journal of Medical Sciences 2017;33(2):452-6. [DOI: 10.12669/pjms.332.12376] - DOI - PMC - PubMed
Review Manager 2020 [Computer program]
-
- Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.
Roque 2014
Rusic 2021
Sakeena 2018
Servia‐Dopazo 2018
Sriviriyanupap 2018
-
- Sriviriyanupap W, Sutapuk U. Ethical cases on professional pharmacy practice in Thailand during A.D. 1995–2015. The Journal of Pharmaceutical Science 2018;42:97-101. [URL: www.thaiscience.info/Journals/Article/TJPS/10989634.pdf]
Stenson 2001
-
- Stenson B, Syhakhang L, Lundborg CS, Eriksson B, Tomson G. Private pharmacy practice and regulation: a randomised trial in Lao PDR. International Journal of Technology Assessment in Health Care 2001;17(4):579-89. [PMID: ] - PubMed
Sterne 2011
Sterne 2019
-
- Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:14898. [DOI: ] - PubMed
Sudhinaraset 2013
Sunpuwan 2019
Thamby 2014
-
- Thamby SA, Subramani P. Seven-star pharmacist concept by World Health Organization. Journal of Young Pharmacists 2014;6(2):1-3. [DOI: 10.5530/jyp.2014.2.1] - DOI
The Royal Thai Government 1967
-
- The Royal Thai Government. The Drug Act of Thailand B.E. 1967. extwprlegs1.fao.org/docs/pdf/tha181028.pdf (accessed 4 March 2022).
Ung 2017
-
- Ung E, Czarniak P, Sunderland B, Parsons R, Hoti K. Assessing pharmacists' readiness to prescribe oral antibiotics for limited infections using a case-vignette technique. Int J Clin Pharm 2017;39(1):61-9. [DOI: doi: 10.1007/s11096-016-0396-0] [PMID: PMID: 27848173] - PubMed
van Hecke 2017
Vlaev 2019
Watkins 2015
WHO 1994
-
- World Health Organization. The role of the pharmacist in the health care system: report of a WHO consultative group, New Delhi, India, 13-16 December 1988; report of a WHO meeting, Tokyo, Japan, 31 August - 3 September 1993. apps.who.int/iris/handle/10665/59169 (accessed 15 October 2019).
WHO 2001
-
- World Health Organization. Global strategy for containment of AMR. www.who.int/drugresistance/WHO_Global_Strategy_English.pdf (accessed 15 October 2019).
WHO 2014
-
- World Health Organization. Antimicrobial resistance: global report on surveillance. apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf (accessed 15 October 2019).
WHO 2015
-
- World Health Organization. Global action plan on antimicrobial resistance. www.wpro.who.int/entity/drug_resistance/resources/global_action_plan_eng... (accessed 15 October 2019).
WHO 2018a
-
- World Health Organization. Fact sheet on antimicrobial resistance. www.who.int/antimicrobial-resistance/en/ (accessed 15 October 2019).
WHO 2018b
-
- Monitoring global progress on addressing antimicrobial resistance: analysis report of the second round of results of AMR country self-assessment survey 2018. www.who.int/publications/i/item/monitoring-global-progress-on-addressing... (accessed 21 February 2022).
Wirtz 2013
-
- Wirtz VJ, Herrera-Patino JJ, Santa-Ana-Tellez Y, Dreser A, Elseviers M, Vander Stichele RH. Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries. Trop Med Int Health 2013;18(6):665-73. [DOI: doi: 10.1111/tmi.12096] [PMID: PMID: 23551290] - PubMed
World Bank 2017
-
- World Bank. Drug-resistant infections: a threat to our economic future. documents.worldbank.org/curated/en/323311493396993758/pdf/final-report.pdf (accessed on 25 November 2019).
World Bank Group 2020
-
- World Bank Group. Country and Leading Groups. datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-coun... (accessed 25 May 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical